2011
DOI: 10.1371/journal.pone.0017010
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral Characterization of a Mouse Model Overexpressing DSCR1/ RCAN1

Abstract: DSCR1/ RCAN1 is a chromosome 21 gene found to be overexpressed in the brains of Down syndrome (DS) and postulated as a good candidate to contribute to mental disability. However, even though Rcan1 knockout mice have pronounced spatial learning and memory deficits, the possible deleterious effects of its overexpression in DS are not well understood. We have generated a transgenic mouse model overexpressing DSCR1/RCAN1 in the brain and analyzed the effect of RCAN1 overexpression on cognitive function. TgRCAN1 mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
35
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(38 citation statements)
references
References 24 publications
2
35
0
1
Order By: Relevance
“…Nonetheless, the combined overexpression of RCAN1 and DYRK1A has now been identified as a possible key contributor to some phenotypes of Down syndrome etiology [20,[22][23][24][25]. We believe that a simple, healthy, and cost-effective approach to treating Down syndrome (and possibly associated Alzheimer) is to identify nutraceuticals that reduce RCAN1 and DYRK1A levels, in turn, activating NF-AT signaling (usually represented by NF-AT dephosphorylation).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nonetheless, the combined overexpression of RCAN1 and DYRK1A has now been identified as a possible key contributor to some phenotypes of Down syndrome etiology [20,[22][23][24][25]. We believe that a simple, healthy, and cost-effective approach to treating Down syndrome (and possibly associated Alzheimer) is to identify nutraceuticals that reduce RCAN1 and DYRK1A levels, in turn, activating NF-AT signaling (usually represented by NF-AT dephosphorylation).…”
Section: Discussionmentioning
confidence: 99%
“…One such chromosome 21 gene is RCAN1 (regulator of calcineurin 1). This gene has become one of the leading candidates for contributing to some (but not all) phenotypes of Down syndrome [19][20][21][22][23][24]. RCAN1 has also been implicated in Alzheimer disease, and early-onset Alzheimer disease is a much higher risk in Down syndrome [19,23,24].…”
Section: Introductionmentioning
confidence: 99%
“…Following these positive outcomes, a human clinical trial has been recently completed, although no results have been published so far (NCT01394796). A more recent mouse model, TgRCAN1, also highlighted the impact of the overexpression of DSCR1 (RCAN1), a functional inhibitor of calcineurin, in visuo-spatial learning and memory tasks similar to those present in Down syndrome affected persons (Dierssen et al, 2011). Other studies exploring the hypothesis of high levels of inhibition being involved in Down syndrome cognitive dysfunction also revealed promising results.…”
Section: Down Syndromementioning
confidence: 99%
“…Specifically, it has been found a relationship between the overexpression of these genes and the emergence of alterations in brain plasticity, in the neuronal branches extension and cerebral apoptosis processes. And as to the behavioral characteristics it has been found a link between these genes and alterations in spatial learning, acquisition of locomotion or the exploratory behavior (Altafaj et al, 2001;Chrast et al, 2000;Dierssen et al, 2011;Donato, 2003;Lopes, Chettouh, Delabar & Rachidi, 2003;Martínez et al, 2008;Park et al, 2009;Yabut, Domagauer & D"Arcangelo, 2010).…”
Section: Transgenic Micementioning
confidence: 99%